Apr. 9—Medical Center Hospital is proud to announce that Dr. Manohar Angirekula, Dr. Adam Farber and Dr. Fernando Boccalandro successfully implanted the first WATCHMAN FLX Pro Device on April 1. MCH ...

The WATCHMAN FLX Pro team (pictured here) has successfully completed 159 WATCHMAN procedures, and will now only use the updated WATCHMAN FLX Pro Device moving forward. (Courtesy Photo) Medical Center ...

The Cottage Heart & Vascular Center’s structural heart team at Santa Barbara Cottage Hospital (SBCH) recently performed their 1,000th WATCHMAN device procedure, a minimally invasive solution for ...

ODESSA, Texas — Medical Center Hospital has successfully completed the first four WATCHMAN™ procedures. This permanent heart implant is the only FDA-approved device that reduces the stroke risk for ...

CHI Memorial and The Chattanooga Heart Institute announce they will offer a new procedure to treat atrial fibrillation (AFib). The WATCHMAN device is an alternative to the lifelong use of ...

In September 2017, members of MidMichigan Health's comprehensive Heart and Vascular Program began performing a new minimally invasive procedure to prevent stroke in patients with atrial fibrillation ...

Michelle Judy, the structural heart coordinator, holds up the box for the WATCHMAN FLX Pro Device as interventional cardiologist Dr. Fernando Boccalandro explains what it does at Medical Center ...

Shaped like a small jellyfish or pumpkin no bigger than the size of a Ping-Pong ball, the Watchman device helps prevent stroke in people with atrial fibrillation (A-fib) by sealing off part of the ...

MedStar Heart & Vascular Institute now offers patients with irregular heart rhythm a minimally invasive option to reduce the risk of stroke, as well as enable stopping long-term use of blood thinning ...

ST. CLOUD — CentraCare became the first in the world to use a 4D hologram to visualize a patient's organs during a structural heart procedure last month. By Thursday morning, Dr. Jacob Dutcher was ...

SWISS-APERO is the first randomized clinical trial comparing Amulet with the new generation Watchman FLX device in terms of residual left atrial appendage (LAA) patency after percutaneous LAA closure ...